Robert joined Catapult in 2023 following a PhD in molecular Cancer Studies at the University of Manchester, investigating spatiotemporal protein-protein interactions in response to cytotoxic chemotherapies, and postdoctoral research posts utilising spatial biology techniques (high-plex immuno-staining, laser-capture microdissection in conjunction with LC-MS/MS) to identify biomarker of cancer risk in at-risk patient cohorts.
Robert’s current interests are in using the latest spatial biology technologies to generate holistic insights into the pathobiology of diseased tissues and exploiting this knowledge to identify clinically relevant molecular biomarkers of disease.
